文献速递心境障碍

深部脑刺激治疗难治性抑郁症:临床前与临床发现的整合综述

Deep brain stimulation for treatment-resistant depression: an integrative review of preclinical and clinical findings and translational implications.
PubMed 文献 · Mol Psychiatry · 2018-02-27

本文整合综述了深部脑刺激(DBS)治疗难治性抑郁症(TRD)的临床前与临床证据,共纳入92篇参考文献,评估了六个脑刺激靶点。临床前证据提示刺激参数和靶点位置影响抗抑郁效应,单胺能调节可能参与其中;SCG、ALIC和MFB靶点的抗抑郁应答率较为一致,但仍需更多随机双盲对照试验验证。

要点

  • DBS治疗TRD的疗效尚不明确,需更多随机双盲对照试验验证。
  • SCG、ALIC和MFB靶点的抗抑郁应答率较为一致。
  • 刺激参数和靶点位置可能影响DBS抗抑郁效应。

核心结论

  • DBS对TRD的疗效尚不明确,SCG、ALIC和MFB靶点显示出较为一致的抗抑郁应答率,但需更多随机双盲对照试验验证。

研究设计与样本

  • 整合综述,检索主要电子数据库,纳入92篇参考文献,评估六个DBS靶点(SCG、NAc、ALIC、MFB、LHb、下丘脑脚)。

主要发现

  • 六个DBS靶点对TRD患者情绪转换显示不同效应。
  • 47篇独特参考文献提供临床前证据,涉及vmPFC、NAc、MFB、LHb和丘脑底核。
  • 临床前研究提示刺激参数和神经解剖位置可能影响DBS抗抑郁效应。
  • DBS对靶区或互联脑网络单胺能神经递质的调节可能参与抗抑郁效应。
  • SCG、ALIC和MFB靶点的抗抑郁应答率在TRD样本中较为一致。

临床怎么用

  • SCG、ALIC和MFB可作为TRD患者DBS治疗的潜在优先靶点,但需在随机双盲对照试验框架下谨慎应用。

局限性

  • 部分对照研究中治疗效果不一致,需更多设计良好的随机双盲对照试验评估疗效、安全性和耐受性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although deep brain stimulation (DBS) is an established treatment choice for Parkinson's disease (PD), essential tremor and movement disorders, its effectiveness for the management of treatment-resistant depression (TRD) remains unclear. Herein, we conducted an integrative review on major neuroanatomical targets of DBS pursued for the treatment of intractable TRD. The aim of this review article is to provide a critical discussion of possible underlying mechanisms for DBS-generated antidepressant effects identified in preclinical studies and clinical trials, and to determine which brain target(s) elicited the most promising outcomes considering acute and maintenance treatment of TRD. Major electronic databases were searched to identify preclinical and clinical studies that have investigated the effects of DBS on depression-related outcomes. Overall, 92 references met inclusion criteria, and have evaluated six unique DBS targets namely the subcallosal cingulate gyrus (SCG), nucleus accumbens (NAc), ventral capsule/ventral striatum or anterior limb of internal capsule (ALIC), medial forebrain bundle (MFB), lateral habenula (LHb) and inferior thalamic peduncle for the treatment of unrelenting TRD. Electrical stimulation of these pertinent brain regions displayed differential effects on mood transition in patients with TRD. In addition, 47 unique references provided preclinical evidence for putative neurobiological mechanisms underlying antidepressant effects of DBS applied to the ventromedial prefrontal cortex, NAc, MFB, LHb and subthalamic nucleus. Preclinical studies suggest that stimulation parameters and neuroanatomical locations could influence DBS-related antidepressant effects, and also pointed that modulatory effects on monoamine neurotransmitters in target regions or interconnected brain networks following DBS could have a role in the antidepressant effects of DBS. Among several neuromodulatory targets that have been investigated, DBS in the neuroanatomical framework of the SCG, ALIC and MFB yielded more consistent antidepressant response rates in samples with TRD. Nevertheless, more well-designed randomized double-blind, controlled trials are warranted to further assess the efficacy, safety and tolerability of these more promising DBS targets for the management of TRD as therapeutic effects have been inconsistent across some controlled studies.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Dandekar MP, Fenoy AJ, Carvalho AF, et al. Deep brain stimulation for treatment-resistant depression: an integrative review of preclinical and clinical findings and translational implications. Mol Psychiatry. 2018. PMID: 29483673. doi:10.1038/mp.2018.2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。